Clinical responses and persistent BRAF V600E + blood cells in children with LCH treated with MAPK pathway inhibition

Blood. 2019 Apr 11;133(15):1691-1694. doi: 10.1182/blood-2018-10-878363. Epub 2019 Feb 4.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Blood Cells
  • Child
  • Databases, Genetic
  • Histiocytosis, Langerhans-Cell*
  • Humans
  • Mutation
  • Proto-Oncogene Proteins B-raf / genetics*

Substances

  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf